{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T05:12:04Z","timestamp":1738041124065,"version":"3.33.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,26]]},"DOI":"10.7759\/cureus.78024","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:37:49Z","timestamp":1737952669000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Hepatic Squamous Cell Carcinoma With Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation: A Case Report"],"prefix":"10.7759","author":[{"given":"Ryogo","family":"Minami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S290523","article-title":"Primary squamous cell carcinoma of the liver is rare but hostile: case series and comprehensive review of the literature","volume":"13","author":"Xiao J","year":"2021","unstructured":"Xiao J, Ma L, Li J, Yin B, Liang J, Wang J. Primary squamous cell carcinoma of the liver is rare but hostile: case series and comprehensive review of the literature. Cancer Manag Res. 2021, 13:829-37. 10.2147\/CMAR.S290523","journal-title":"Cancer Manag Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000868","article-title":"Primary squamous cell carcinoma of liver: case series and review of literatures","volume":"94","author":"Zhang XF","year":"2015","unstructured":"Zhang XF, Du ZQ, Liu XM, Lv Y. Primary squamous cell carcinoma of liver: case series and review of literatures. Medicine (Baltimore). 2015, 94:e868. 10.1097\/MD.0000000000000868","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2016.22.1.177","article-title":"Primary squamous cell carcinoma of the liver: a case report","volume":"22","author":"Yoo TK","year":"2016","unstructured":"Yoo TK, Kim BI, Han EN, et al.. Primary squamous cell carcinoma of the liver: a case report. Clin Mol Hepatol. 2016, 22:177-82. 10.3350\/cmh.2016.22.1.177","journal-title":"Clin Mol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s43066-020-00032-0","article-title":"Primary squamous cell carcinoma of the liver: an unexpected pathological finding","volume":"10","author":"Tuminello F","year":"2020","unstructured":"Tuminello F, Castiglione D, Broggi G, Vecchio GM, Basile A, Puleo S, Pesce A. Primary squamous cell carcinoma of the liver: an unexpected pathological finding. Egypt Liver J. 2020, 10:17. 10.1186\/s43066-020-00032-0","journal-title":"Egypt Liver J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000523857","article-title":"Primary squamous cell carcinoma of the liver: case report and review of literature","volume":"15","author":"Fakhreddine O","year":"2022","unstructured":"Fakhreddine O, Fadlallah Y, Turfa J, Hassan MA, Chamseddine N, Assi HI. Primary squamous cell carcinoma of the liver: case report and review of literature. Case Rep Oncol. 2022, 15:480-5. 10.1159\/000523857","journal-title":"Case Rep Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0654","article-title":"Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type","volume":"23","author":"Gatalica Z","year":"2014","unstructured":"Gatalica Z, Snyder C, Maney T, et al.. Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type. Cancer Epidemiol Biomarkers Prev. 2014, 23:2965-70. 10.1158\/1055-9965.EPI-14-0654","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211021275","article-title":"Primary squamous cell carcinoma of the liver: a case report","volume":"49","author":"Sun Y","year":"2021","unstructured":"Sun Y, Jin G. Primary squamous cell carcinoma of the liver: a case report. J Int Med Res. 2021, 49:3000605211021275. 10.1177\/03000605211021275","journal-title":"J Int Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/030089160509100113","article-title":"Complete remission of poorly differentiated squamous liver carcinoma after systemic chemotherapy and surgery. A case report","volume":"91","author":"Boscolo G","year":"2005","unstructured":"Boscolo G, Jirillo A, Da Pian P. Complete remission of poorly differentiated squamous liver carcinoma after systemic chemotherapy and surgery. A case report. Tumori. 2005, 91:71-2. 10.1177\/030089160509100113","journal-title":"Tumori"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-022-01740-3","article-title":"Curative surgery for primary squamous cell carcinoma of the liver: a rare case study","volume":"16","author":"Okuda Y","year":"2023","unstructured":"Okuda Y, Abe T, Ikeda M, et al.. Curative surgery for primary squamous cell carcinoma of the liver: a rare case study. Clin J Gastroenterol. 2023, 16:263-9. 10.1007\/s12328-022-01740-3","journal-title":"Clin J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000090996","article-title":"Primary squamous cell carcinoma of the colon associated with hypercalcemia and hyperleukocytosis: report of a case","volume":"22","author":"Yitta S","year":"2005","unstructured":"Yitta S, Liang MK, Berman R, Carter JJ, Yee HT, Marks JL. Primary squamous cell carcinoma of the colon associated with hypercalcemia and hyperleukocytosis: report of a case. Dig Surg. 2005, 22:371-4. 10.1159\/000090996","journal-title":"Dig Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF00360355","article-title":"Primary adenosquamous and squamous cell carcinoma of the colon and rectum","volume":"7","author":"Schneider TA 2nd","year":"1992","unstructured":"Schneider TA 2nd, Birkett DH, Vernava AM 3rd. Primary adenosquamous and squamous cell carcinoma of the colon and rectum. Int J Colorectal Dis. 1992, 7:144-7. 10.1007\/BF00360355","journal-title":"Int J Colorectal Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(88)80532-x","article-title":"Primary squamous cell carcinoma of the colon arising in a villous adenoma","volume":"19","author":"Lundquest DE","year":"1988","unstructured":"Lundquest DE, Marcus JN, Thorson AG, Massop D. Primary squamous cell carcinoma of the colon arising in a villous adenoma. Hum Pathol. 1988, 19:362-4. 10.1016\/s0046-8177(88)80532-x","journal-title":"Hum Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i33.5419","article-title":"Primary squamous cell carcinoma of the liver: a successful surgically treated case","volume":"12","author":"Lee HL","year":"2006","unstructured":"Lee HL, Liu YY, Yeh CN, Chiang KC, Chen TC, Jan YY. Primary squamous cell carcinoma of the liver: a successful surgically treated case. World J Gastroenterol. 2006, 12:5419-21. 10.3748\/wjg.v12.i33.5419","journal-title":"World J Gastroenterol"},{"key":"ref14","article-title":"Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas","volume":"136","author":"Ramaekers F","year":"1990","unstructured":"Ramaekers F, van Niekerk C, Poels L, et al.. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol. 1990, 136:641-55.","journal-title":"Am J Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880175","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases","volume":"13","author":"Chu P","year":"2000","unstructured":"Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000, 13:962-72. 10.1038\/modpathol.3880175","journal-title":"Mod Pathol"},{"key":"ref16","article-title":"Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies","volume":"140","author":"Moll R","year":"1992","unstructured":"Moll R, L\u00f6we A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992, 140:427-47.","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58121864","article-title":"Primary squamous cell carcinoma of the liver with good response to carboplatin and 5-flurouracil: a case report","volume":"58","author":"Lee HL","year":"2022","unstructured":"Lee HL, Fu CK, Chien LY, Chen LM. Primary squamous cell carcinoma of the liver with good response to carboplatin and 5-flurouracil: a case report. Medicina (Kaunas). 2022, 58:1864. 10.3390\/medicina58121864","journal-title":"Medicina (Kaunas)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s005350200010","article-title":"Primary squamous cell carcinoma of the liver producing parathyroid hormone-related protein","volume":"37","author":"Saito T","year":"2002","unstructured":"Saito T, Harada K, Tsuneyama K, et al.. Primary squamous cell carcinoma of the liver producing parathyroid hormone-related protein. J Gastroenterol. 2002, 37:138-42. 10.1007\/s005350200010","journal-title":"J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-004-2941-z","article-title":"Primary squamous cell carcinoma of the liver arising from a complex liver cyst: report of a case","volume":"35","author":"Hsieh CB","year":"2005","unstructured":"Hsieh CB, Chen CJ, Yu JC, Chang TM, Gao HW, Liu YC. Primary squamous cell carcinoma of the liver arising from a complex liver cyst: report of a case. Surg Today. 2005, 35:328-31. 10.1007\/s00595-004-2941-z","journal-title":"Surg Today"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000334425","article-title":"Primary squamous cell carcinoma of the liver: an uncommon finding in contrast-enhanced ultrasonography imaging","volume":"5","author":"Iimuro Y","year":"2011","unstructured":"Iimuro Y, Asano Y, Suzumura K, et al.. Primary squamous cell carcinoma of the liver: an uncommon finding in contrast-enhanced ultrasonography imaging. Case Rep Gastroenterol. 2011, 5:628-35. 10.1159\/000334425","journal-title":"Case Rep Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2013.07.030","article-title":"Ciliated hepatic cyst leading to squamous cell carcinoma of the liver - a case report and review of the literature","volume":"4","author":"Wilson JM","year":"2013","unstructured":"Wilson JM, Groeschl R, George B, Turaga KK, Patel PJ, Saeian K, Gamblin TC. Ciliated hepatic cyst leading to squamous cell carcinoma of the liver - a case report and review of the literature. Int J Surg Case Rep. 2013, 4:972-5. 10.1016\/j.ijscr.2013.07.030","journal-title":"Int J Surg Case Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2018.12.004","article-title":"Primary hepatic squamous cell carcinoma with abdominal incision metastasis after hepatectomy","volume":"18","author":"Mao JX","year":"2019","unstructured":"Mao JX, Teng F, Yuan H, et al.. Primary hepatic squamous cell carcinoma with abdominal incision metastasis after hepatectomy. Hepatobiliary Pancreat Dis Int. 2019, 18:194-8. 10.1016\/j.hbpd.2018.12.004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9939898","article-title":"Hepatic squamous cell carcinoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration","volume":"2021","author":"Yamada K","year":"2021","unstructured":"Yamada K, Shinoura S, Kikuchi K. Hepatic squamous cell carcinoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Case Rep Gastrointest Med. 2021, 2021:9939898. 10.1155\/2021\/9939898","journal-title":"Case Rep Gastrointest Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31737","article-title":"Primary hepatic squamous cell carcinoma with high microsatellite instability shows good response to programmed cell death 1 inhibitor as adjuvant therapy","volume":"74","author":"Wang K","year":"2021","unstructured":"Wang K, Lu C, Sun JN, et al.. Primary hepatic squamous cell carcinoma with high microsatellite instability shows good response to programmed cell death 1 inhibitor as adjuvant therapy. Hepatology. 2021, 74:1695-7. 10.1002\/hep.31737","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i19.6744","article-title":"Primary squamous cell carcinoma of the liver: a case report","volume":"10","author":"Kang LM","year":"2022","unstructured":"Kang LM, Yu DP, Zheng Y, Zhou YH. Primary squamous cell carcinoma of the liver: a case report. World J Clin Cases. 2022, 10:6744-9. 10.12998\/wjcc.v10.i19.6744","journal-title":"World J Clin Cases"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/1120009x.1993.11739242","article-title":"Cisplatin and 5-fluorouracil as induction chemotherapy followed by radiation therapy in metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck. A phase II study","volume":"5","author":"Jeremic B","year":"1993","unstructured":"Jeremic B, Zivic DJ, Matovic M, Marinkovic J. Cisplatin and 5-fluorouracil as induction chemotherapy followed by radiation therapy in metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck. A phase II study. J Chemother. 1993, 5:262-5. 10.1080\/1120009x.1993.11739242","journal-title":"J Chemother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/07357909509094459","article-title":"Cisplatin and 5-fluorouracil for metastatic squamous cell carcinoma from unknown primary","volume":"13","author":"Khansur T","year":"1995","unstructured":"Khansur T, Allred C, Little D, Anand V. Cisplatin and 5-fluorouracil for metastatic squamous cell carcinoma from unknown primary. Cancer Invest. 1995, 13:263-6. 10.3109\/07357909509094459","journal-title":"Cancer Invest"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0699","article-title":"Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer","volume":"18","author":"Brooks AN","year":"2012","unstructured":"Brooks AN, Kilgour E, Smith PD. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer. Clin Cancer Res. 2012, 18:1855-62. 10.1158\/1078-0432.CCR-11-0699","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.8","article-title":"Advances and challenges in targeting FGFR signalling in cancer","volume":"17","author":"Babina IS","year":"2017","unstructured":"Babina IS, Turner NC. Advances and challenges in targeting FGFR signalling in cancer. Nat Rev Cancer. 2017, 17:318-32. 10.1038\/nrc.2017.8","journal-title":"Nat Rev Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3212","article-title":"The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing","volume":"22","author":"Helsten T","year":"2016","unstructured":"Helsten T, Elkin S, Arthur E, Tomson BN, Carter J, Kurzrock R. The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing. Clin Cancer Res. 2016, 22:259-67. 10.1158\/1078-0432.CCR-14-3212","journal-title":"Clin Cancer Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01157-0","article-title":"Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance","volume":"124","author":"Krook MA","year":"2021","unstructured":"Krook MA, Reeser JW, Ernst G, et al.. Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance. Br J Cancer. 2021, 124:880-92. 10.1038\/s41416-020-01157-0","journal-title":"Br J Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.007","article-title":"Molecular targeted therapies: ready for \"prime time\" in biliary tract\u00a0cancer","volume":"73","author":"Lamarca A","year":"2020","unstructured":"Lamarca A, Barriuso J, McNamara MG, Valle JW. Molecular targeted therapies: ready for \"prime time\" in biliary tract\u00a0cancer. J Hepatol. 2020, 73:170-85. 10.1016\/j.jhep.2020.03.007","journal-title":"J Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00275-9","article-title":"Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study","volume":"24","author":"Pant S","year":"2023","unstructured":"Pant S, Schuler M, Iyer G, et al.. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study. Lancet Oncol. 2023, 24:925-35. 10.1016\/S1470-2045(23)00275-9","journal-title":"Lancet Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0766","article-title":"Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib","volume":"11","author":"Silverman IM","year":"2021","unstructured":"Silverman IM, Hollebecque A, Friboulet L, et al.. Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib. Cancer Discov. 2021, 11:326-39. 10.1158\/2159-8290.CD-20-0766","journal-title":"Cancer Discov"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/1073274821989314","article-title":"Intrahepatic cholangiocarcinoma: state of the art of FGFR inhibitors","volume":"28","author":"Wu T","year":"2021","unstructured":"Wu T, Jiang X, Zhang X, et al.. Intrahepatic cholangiocarcinoma: state of the art of FGFR inhibitors. Cancer Control. 2021, 28:1073274821989314. 10.1177\/1073274821989314","journal-title":"Cancer Control"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/231912-clinical-outcomes-of-hepatic-squamous-cell-carcinoma-with-fibroblast-growth-factor-receptor-2-fgfr2-mutation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:37:52Z","timestamp":1737952672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/231912-clinical-outcomes-of-hepatic-squamous-cell-carcinoma-with-fibroblast-growth-factor-receptor-2-fgfr2-mutation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.78024","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,26]]}}}